---
figid: PMC5510573__eje-177-R125-g002
figtitle: Overview of the human androgen biosynthesis pathways
organisms:
- NA
pmcid: PMC5510573
filename: eje-177-R125-g002.jpg
figlink: /pmc/articles/PMC5510573/figure/fig2/
number: F2
caption: 'Overview of the human androgen biosynthesis pathways. Pregnenolone (PREG),
  produced by the side-chain cleavage of cholesterol, is the common precursor of all
  androgen biosynthesis pathways. The classical pathways, proceeding parallel for
  ∆5- and ∆4-precursors, lead to the formation of testosterone (T), which can be converted
  to dihydrotestosterone (DHT). The alternate 5α-dione pathway and ‘backdoor’ pathway
  directly synthesise DHT by-passing T. The 11-oxygenated androgen pathway converts
  androstenedione (A4) to 11β-hydroxyandrostenedione (11OHA4) by adrenal 11β-hydroxylase
  (CYP11B1) activity, generating the active androgens 11-keto-testosterone (11KT)
  and 11-keto-dihydrotestosterone (11KDHT). CYP17A1 capable of both 17α-hydroxylase
  and 17,20-lyase activity. All androgen receptor-transactivating androgens (T, DHT,
  11KT and 11KDHT) are highlighted in bold and white boxes. Enzymes upregulated in
  PCOS contributing to local and systemic androgen excess (steroid 5α-reductase, 5αRed;
  17β-hydroxysteroid dehydrogenase, 17βHSD) are highlighted in bold. Impaired activity
  of sulfotransferase 2A1 (SULT, underlined) due to mutations of the co-factor synthesising
  PAPS synthase 2 leads to a PCOS-like phenotype. Androstenedione and T can be converted
  to the oestrogens estrone (E1) and estradiol (E2), respectively, by aromatase (CYP19A1),
  whose activity possibly enhances androgen deficiency in obese men. Steroid abbreviations:
  3α-diol, 5α-androstanediol; 5α-dione, 5α-androstanedione; 5-diol, androstene-diol;
  11KA4, 11-keto-androstenedione; 11OHDHT, 11β-hydroxytestosterone; 17OH-AlloP, 17-hydroxyallopregnanolone;
  17OH-DHP, 17-hydroxydihydroprogesterone; 17OH-PREG, 17-hydroxypregnenolone; 17OH-PROG,
  17-hydroxyprogesterone; AlloP, allopregnanolone; An, androsterone; DHEA, dehydroepiandrosterone;
  DHEAS, dehydroepiandrosterone sulfate; DHP, 5α-dihydroprogestrone; PROG, progesterone.
  Enzyme abbreviations: STS, steroid sulfatase; 3β-HSD, 3β-hydroxysteroid dehydrogenase/∆4–5
  isomerase; 11βHSD2, 11β-hydroxysteroid dehydrogenase type 2; cytb5, cytochrome b5.'
papertitle: 'MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens
  in human metabolic disease.'
reftext: Lina Schiffer, et al. Eur J Endocrinol. 2017 Sep;177(3):R125-R143.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9380528
figid_alias: PMC5510573__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC5510573__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5510573__eje-177-R125-g002.html
  '@type': Dataset
  description: 'Overview of the human androgen biosynthesis pathways. Pregnenolone
    (PREG), produced by the side-chain cleavage of cholesterol, is the common precursor
    of all androgen biosynthesis pathways. The classical pathways, proceeding parallel
    for ∆5- and ∆4-precursors, lead to the formation of testosterone (T), which can
    be converted to dihydrotestosterone (DHT). The alternate 5α-dione pathway and
    ‘backdoor’ pathway directly synthesise DHT by-passing T. The 11-oxygenated androgen
    pathway converts androstenedione (A4) to 11β-hydroxyandrostenedione (11OHA4) by
    adrenal 11β-hydroxylase (CYP11B1) activity, generating the active androgens 11-keto-testosterone
    (11KT) and 11-keto-dihydrotestosterone (11KDHT). CYP17A1 capable of both 17α-hydroxylase
    and 17,20-lyase activity. All androgen receptor-transactivating androgens (T,
    DHT, 11KT and 11KDHT) are highlighted in bold and white boxes. Enzymes upregulated
    in PCOS contributing to local and systemic androgen excess (steroid 5α-reductase,
    5αRed; 17β-hydroxysteroid dehydrogenase, 17βHSD) are highlighted in bold. Impaired
    activity of sulfotransferase 2A1 (SULT, underlined) due to mutations of the co-factor
    synthesising PAPS synthase 2 leads to a PCOS-like phenotype. Androstenedione and
    T can be converted to the oestrogens estrone (E1) and estradiol (E2), respectively,
    by aromatase (CYP19A1), whose activity possibly enhances androgen deficiency in
    obese men. Steroid abbreviations: 3α-diol, 5α-androstanediol; 5α-dione, 5α-androstanedione;
    5-diol, androstene-diol; 11KA4, 11-keto-androstenedione; 11OHDHT, 11β-hydroxytestosterone;
    17OH-AlloP, 17-hydroxyallopregnanolone; 17OH-DHP, 17-hydroxydihydroprogesterone;
    17OH-PREG, 17-hydroxypregnenolone; 17OH-PROG, 17-hydroxyprogesterone; AlloP, allopregnanolone;
    An, androsterone; DHEA, dehydroepiandrosterone; DHEAS, dehydroepiandrosterone
    sulfate; DHP, 5α-dihydroprogestrone; PROG, progesterone. Enzyme abbreviations:
    STS, steroid sulfatase; 3β-HSD, 3β-hydroxysteroid dehydrogenase/∆4–5 isomerase;
    11βHSD2, 11β-hydroxysteroid dehydrogenase type 2; cytb5, cytochrome b5.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SULT2A1
  - STS
  - CYTB
  - HSD17B1
  - RNU105B
  - ELSPBP1
  - HSD3B1
  - IGBP1
  - DPYD
  - DPYS
  - AKR1C4
  - DHRS9
  - AN
  - CYP19A1
  - sts
  - Cyt-b5-r
  - a5
  - Prosalpha5
  - Prosalpha4
  - alphaTub67C
  - nAChRalpha4
  - CRMP
  - an
  - androgen
  - DHEA
---
